Piper Sandler Reiterates Overweight Rating, Would Buy Oncorus Inc. (ONCR) on Weakness
Tweet Send to a Friend
Piper Sandler analyst Christopher Raymond reiterated an Overweight rating and $40.00 price target on Oncorus Inc. (NASDAQ: ONCR) and would ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
